Spencer C A, Nicoloff J T
Clin Chim Acta. 1980 Dec 22;108(3):415-24. doi: 10.1016/0009-8981(80)90349-6.
This study concerns the optimization of the human TSH (h-TSH) radioimmunoassay with special emphasis on reducing the heterogeneity of the 125I h-TSH tracer. Enzymatic iodination of h-TSH with glucose oxidase/lactoperoxidase was shown to be superior to either low or high dose chloramine-T procedures, producing a high specific activity reagent (70--150 microCi/microgram) with minimal evidence of damage. Tracer purification procedures not only affected initial immunoactivity but also storage stability and heterogeneity of the resulting 125I h-TSH. Tracers purified by combining concanavalin A-Sepharose adsorption and high resolution gel filtration (Sephadex G100), produced significantly lower (p less than 0.001) serum h-TSH measurements than were observed in less purified tracer materials. Concanavalin A-Sepharose adsorption yield of the 125I h-TSH iodination products closely correlated with the yield (r = 0.85, p less than 0.001) and immunoactivity (r = 0.90, p less than 0.001) of the tracer produced, thus making this an ideal method for initial tracer purification. Storage of tracer adsorbed to a solid support (concanavalin A-Sepharose) reduced technical manipulations without compromising tracer performance. Loss of specific activity was minimized by storage at -70 degrees C. The assay developed using these technical approaches showed a sensitivity limit of 0.005 +/- 0.001 (S.E.M.) microU/tube; 50% displacement at 0.18 +/- 0.08 (S.E.M.) microU/tube and complete delineation between euthyroid (n = 49, 2.44 +/- 0.18 (S.E.M.) mU/l, range 1.00--6.08) and hyperthyroid (n = 62, 0.34 +/- 0.02 (S.E.M.) mU/l, range 0.10--0.85), serum h-TSH levels.
本研究关注人促甲状腺激素(h-TSH)放射免疫测定法的优化,特别着重于降低125I h-TSH示踪剂的异质性。已证明用葡萄糖氧化酶/乳过氧化物酶对h-TSH进行酶促碘化优于低剂量或高剂量氯胺-T法,可产生具有高比活性的试剂(70 - 150微居里/微克),且损伤迹象最小。示踪剂纯化程序不仅影响初始免疫活性,还影响所得125I h-TSH的储存稳定性和异质性。通过结合伴刀豆球蛋白A - 琼脂糖吸附和高分辨率凝胶过滤(葡聚糖G100)纯化的示踪剂,其血清h-TSH测量值显著低于(p < 0.001)在纯化程度较低的示踪剂材料中观察到的值。125I h-TSH碘化产物的伴刀豆球蛋白A - 琼脂糖吸附产率与所得示踪剂的产率(r = 0.85,p < 0.001)和免疫活性(r = 0.90,p < 0.001)密切相关,因此这是示踪剂初始纯化的理想方法。吸附到固相载体(伴刀豆球蛋白A - 琼脂糖)上的示踪剂储存减少了技术操作,同时不影响示踪剂性能。通过在 - 70℃储存可使比活性损失最小化。使用这些技术方法开发的测定法显示灵敏度极限为0.005 ± 0.001(标准误)微单位/管;在0.18 ± 0.08(标准误)微单位/管时50%置换,并且能完全区分甲状腺功能正常者(n = 49,2.44 ± 0.18(标准误)mU/l,范围1.00 - 6.08)和甲状腺功能亢进者(n = 62,0.34 ± 0.02(标准误)mU/l,范围0.10 - 0.85)的血清h-TSH水平。